R1 RCM Inc (NASDAQ:RCM) has been given an average broker rating score of 2.00 (Buy) from the two analysts that provide coverage for the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold recommendation and one has assigned a strong buy recommendation to the company. R1 RCM’s rating score has improved by 14.2% from 90 days ago as a result of a number of analysts’ ratings changes.
Brokers have set a 1-year consensus price target of $4.75 for the company and are predicting that the company will post $0.01 EPS for the current quarter, according to Zacks. Zacks has also given R1 RCM an industry rank of 118 out of 265 based on the ratings given to related companies.
Several analysts recently commented on RCM shares. Zacks Investment Research raised shares of R1 RCM from a “strong sell” rating to a “hold” rating in a report on Wednesday, October 4th. Robert W. Baird reissued a “hold” rating and issued a $5.00 price objective on shares of R1 RCM in a report on Tuesday, September 26th.
Shares of R1 RCM (NASDAQ:RCM) traded up $0.05 during mid-day trading on Monday, hitting $4.50. 245,900 shares of the company traded hands, compared to its average volume of 369,785. The company has a market cap of $470.32, a P/E ratio of -16.07 and a beta of -0.47. R1 RCM has a 1-year low of $2.02 and a 1-year high of $4.58.
TRADEMARK VIOLATION WARNING: This piece of content was reported by Week Herald and is the property of of Week Herald. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://weekherald.com/2017/12/25/r1-rcm-inc-rcm-receives-average-rating-of-buy-from-brokerages.html.
About R1 RCM
R1 RCM Inc, formerly Accretive Health, Inc, is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.